[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Submit :: Indexing :: Contact Us ::
:: Volume 12, Issue 3 (Summer(2022) 2022) ::
JABS 2022, 12(3): 292-301 Back to browse issues page
Overcoming Drug Resistance in Breast Cancer Using Quercetin Nanodrugs
Fatemeh Sorayabin Mobarhan1 , Maryam Teimouri 2, Mehdi Pooladi3
1- Department of Biology, Roudehen Branch, Islamic Azad University, Roudehen, Iran
2- Department of Biology, Roudehen Branch, Islamic Azad University, Roudehen, Iran , teimourimaryam93@gmail.com
3- Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
Abstract:   (835 Views)
Background & Objective: Breast cancer is one of the most common cancers in the world. Treatment methods for this disease have been with poor results. In recent years, more attention has been paid to stem cells due to their cytotoxic properties. According to previous results, the effect of nanoquercetin on breast cancer cells in this study was used concomitantly with doxorubicin, which is a chemotherapy drug and in some patients has therapeutic resistance.
Materials & Methods: The above study was performed on MCF7 and BT474 human breast cancer cells. Quercetin was synthesized, then different concentrations of 10, 20, 40, 80 and 160 of quercetin and 1, 2.5, 5 and 10 μg/ml of doxorubicin were prepared and two cell lines were treated for 24 h. MTT test was used to determine cell viability and flow cytometry test was used to determine the extent of apoptosis in both cell lines.
Results: The results showed that MCF7 and BT474 cells that were affected by quercetin and doxorubicin, increasing the concentration of quercetin and doxorubicin decreased the survival of both cell lines within 24 h. The LC50 concentration was calculated for both cells treated with nanoquercetin 40 μg/ml and for doxorubicin doxorubicin (0.1 mg/ml). The results also showed that in both cell lines, an increase in cellular apoptosis occurred after incubation with quercetin and then incubation with doxorubicin.
Conclusion: Comparison of doxorubicin (DOX), quercetin (QU) and quercetin and doxorubicin (QU-DOX) groups with controls shows that with the presence of quercetin-doxorubicin, it had a greater inhibitory effect on cancer cells.
Keywords: Quercetin, Doxorubicin, MCF-7, BT474, Breast Cancer
Full-Text [PDF 500 kb]   (181 Downloads)    
Type of Study: Research | Subject: Oncology
Received: 2021/11/30 | Accepted: 2022/01/12 | Published: 2022/04/13
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sorayabin Mobarhan F, Teimouri M, Pooladi M. Overcoming Drug Resistance in Breast Cancer Using Quercetin Nanodrugs. JABS 2022; 12 (3) :292-301
URL: http://jabs.fums.ac.ir/article-1-2761-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 3 (Summer(2022) 2022) Back to browse issues page
Journal of Advanced Biomedical Sciences
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4509